Skip to NavigationSkip to content

News

These two latest deals build on the base of 85 million vaccine doses that the country has already secured of candidates from CSL and AstraZeneca,...
Biogen’s Alzheimer’s drug aducanumab is on track to be approved by the FDA after a successful late-stage clinical trial.
Immaturity of the supplied data means that cost-effectiveness uncertainties around the drug’s benefit in overall survival could not be adequately...
Psilocybin has substantial and enduring antidepressant effects, according to a new study conducted by a team at John Hopkins University.
Denmark is set to cull its 17 million mink population after it was found a mutation of coronavirus in the animal had spread to humans.
Two of our biggest COVID-19 stories in the past week focus on new deals to ensure that Eli Lilly's and Sanofi/GSK's vaccines can reach all that...
It was found that both drugs generated the same proportion of ACR20 responses at 82.7% each, representing an improvement of at least 20% in patient...
Despite initiating the recall, the company said it had not been made aware of any adverse events related to the drug.
J&J is currently fighting more than 21,8000 lawsuits around the alleged carcinogenic properties of its talc products.
“These findings indicate deucravacitinib has the potential to be a new treatment option for people living with psoriasis and may provide clinically...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches